
Oral Semaglutide Shows Promise in Treating Alcohol Use Disorder
A clinical trial at the University of Colorado Anschutz indicates that oral semaglutide, widely used for diabetes and weight management, significantly curbs heavy drinking. Published in The American Journal of Psychiatry, the findings offer a potential breakthrough for patients struggling with alcohol use who have seen few new treatment options in decades.

























